Search

Your search keyword '"Patel, Priya"' showing total 1,699 results
Start Over Author "Patel, Priya"
1,699 results on '"Patel, Priya"'

4. A Comprehensive Note on Gastro-Retentive Dosage Forms

Author

Patel, Priya, Sahu, Rohini, Joshi, Renjil, Armarkar, Surabhi, Parveen, Tarannum, Pratap, Narendra, Sahu, Renuka, Sahu, Pushpanjali, Sahu, Dujram, Manikpuri, Rupali, Patel, Madhav, Sahu, Tikeshwar, Rajak, Bhupendra, Sahu, Parmanand, Yadav, Pooja, Agrawal, Mukta, Ajazuddin, Tripathi, D. K., and Alexander, Amit

Published
2018
Full Text
View/download PDF

13. Forest Fire Detection and Prediction Using HSV and MLP

Author

Sabnis, Manasvi, Patil, Pradnya, Patel, Priya, Adurkar, Aditi, Kacprzyk, Janusz, Series Editor, Gomide, Fernando, Advisory Editor, Kaynak, Okyay, Advisory Editor, Liu, Derong, Advisory Editor, Pedrycz, Witold, Advisory Editor, Polycarpou, Marios M., Advisory Editor, Rudas, Imre J., Advisory Editor, Wang, Jun, Advisory Editor, Nanda, Satyasai Jagannath, editor, Yadav, Rajendra Prasad, editor, Gandomi, Amir H., editor, and Saraswat, Mukesh, editor

Published
2024
Full Text
View/download PDF

16. Correction to: Clinical and Treatment History of Patients with Partial DiGeorge Syndrome and Autoimmune Cytopenia at Multiple Centers

Author

Patel, Priya K., Chinga, Michell Lozano, Yilmaz, Melis, Joychan, Sonia, Ujhazi, Boglarka, Ellison, Maryssa, Gordon, Sumai, Nieves, Daime, Csomos, Krisztian, Eslin, Don, Afify, Zeinab A., Meznarich, Jessica, Bohnsack, John, Walkovich, Kelly, Seidel, Markus G., Sharapova, Svetlana, Boyarchuk, Oksana, Latysheva, Elena, Tuzankina, Irina, Shaker, Ahmad B., Ayala, Irmel, Sriaroon, Panida, Westermann-Clark, Emma, and Walter, Jolan E.

Published
2024
Full Text
View/download PDF

17. The impact of completion and follow-up endoleaks on survival, reintervention, and rupture.

Author

Li, Chun, de Guerre, Livia, Dansey, Kirsten, Lu, Jinny, Patel, Priya, Yao, Mengdi, Jones, Douglas, Schermerhorn, Marc, and Malas, Mahmoud

Subjects
AAA, Aneurysm, Completion endoleak, EVAR, Follow-up, Humans, Aged, United States, Treatment Outcome, Follow-Up Studies, Blood Vessel Prosthesis Implantation, Risk Factors, Aortic Aneurysm, Abdominal, Medicare, Endoleak, Endovascular Procedures, Retrospective Studies
Abstract

OBJECTIVE: Endoleaks may be seen at case completion of endovascular abdominal aortic aneurysm repair (EVAR), and the presence of an endoleak may impact outcomes. However, the clinical implications of various endoleaks seen during follow-up is not well-described. Therefore, we studied the impact of endoleaks at completion and at follow-up on mid-term outcomes. METHODS: We reviewed patients who underwent EVAR from 2003 to 2016 within the Vascular Quality Initiative-Medicare database and identified patients with endoleak at procedure completion and during follow-up, excluding those presenting with rupture. We stratified cohorts by presence of completion and follow-up endoleak subtypes. The primary outcome was 5-year survival, and secondary outcomes included 5-year freedom from reintervention and freedom from rupture. We used Kaplan-Meier estimates and log-rank tests to analyze differences in time-to-event endpoints. RESULTS: Of 21,745 patients with completion endoleak data, 5085 (23%) had an endoleak. Compared with those without endoleak, those with type I endoleaks had lower 5-year survival (69% vs 75%; P < .001), type II endoleaks had higher survival (79%; P < .001), and types III, IV, and indeterminate were not statistically different (73%, 73%, and 75%, respectively). Freedom from reintervention for types I and III endoleaks were significantly lower than no endoleak cohort (I: 76%; P < .001; III: 72%; P < .001 vs 83%), but freedom from rupture was higher for those with type II and III endoleak (95% and 97% vs 94%; P < .001). Of 14,479 patients with detailed follow-up endoleak data, 2290 (16%) had an endoleak. Compared with those without endoleak, types I and III had significantly lower 5-year survival (I: 80%; P = .002; III: 66%; P < .001 vs 84%), but there were no differences for types II (82%) and indeterminate (77%). Those with any type of follow-up endoleak had lower 5-year freedom from reintervention (I: 70%; P < .001; II: 76%; P = .006; III: 36%; P < .001; indeterminate: 60%; P = .007 vs 84%), and lower freedom from rupture (I: 92%; P < .001; II: 91%; P = .16; III: 88%; P = .01; indeterminate: 90%; P = .11 vs 94%). CONCLUSIONS: Compared with patients with no endoleak, those with type I completion endoleaks have lower 5-year survival and freedom from reintervention. Patients with types I and III follow-up endoleaks also have lower survival, and any endoleak at follow-up is associated with lower freedom from reintervention and freedom from rupture. These data highlight the importance of careful patient selection and close postoperative follow-up after EVAR, as the presence of endoleaks, specifically type I and III, over time portends worse outcomes.

Published
2023

21. Clinical and Treatment History of Patients with Partial DiGeorge Syndrome and Autoimmune Cytopenia at Multiple Centers

Author

Patel, Priya K., Chinga, Michell Lozano, Yilmaz, Melis, Joychan, Sonia, Ujhazi, Boglarka, Ellison, Maryssa, Gordon, Sumai, Nieves, Daime, Csomos, Krisztian, Eslin, Don, Afify, Zeinab A., Meznarich, Jessica, Bohnsack, John, Walkovich, Kelly, Seidel, Markus G., Sharapova, Svetlana, Boyarchyk, Oksana, Latysheva, Elena, Tuzankina, Irina, Shaker, Ahmad B., Ayala, Irmel, Sriaroon, Panida, Westermann-Clark, Emma, and Walter, Jolan E.

Published
2024
Full Text
View/download PDF

22. Outcomes after transcarotid artery revascularization stratified by preprocedural symptom status.

Author

Solomon, Yoel, Rastogi, Vinamr, Marcaccio, Christina, Patel, Priya, Wang, Grace, Motaganahalli, Raghu, Nolan, Brian, Verhagen, Hence, de Borst, Gert, Schermerhorn, Marc, and Malas, Mahmoud

Subjects
Carotid artery stenosis, Carotid artery stenting, Cerebrovascular disease, Stroke, Transcarotid artery revascularization, Humans, Carotid Stenosis, Ischemic Attack, Transient, Stents, Endovascular Procedures, Risk Factors, Treatment Outcome, Time Factors, Stroke, Risk Assessment, Arteries, Retrospective Studies
Abstract

OBJECTIVE: Previous studies on carotid endarterectomy and transfemoral carotid artery stenting demonstrated that perioperative outcomes differed according to preoperative neurologic injury severity, but this has not been assessed in transcarotid artery revascularization (TCAR). In this study, we examined contemporary perioperative outcomes in patients who underwent TCAR stratified by specific preprocedural symptom status. METHODS: Patients who underwent TCAR between 2016 and 2021 in the Vascular Quality Initiative were included. We stratified patients into the following groups based on preprocedural symptoms: asymptomatic, recent (symptoms occurring 180 days before TCAR). First, we used trend tests to assess outcomes in asymptomatic patients versus those with an increasing severity of recent neurologic injury (recent ocular TIA vs recent hemispheric TIA vs recent stroke). Then, we compared outcomes between asymptomatic and formerly symptomatic patients. Our primary outcome was in-hospital stroke/death rates. Multivariable logistic regression was used to adjust for demographics and comorbidities across groups. RESULTS: We identified 18,477 patients undergoing TCAR, of whom 62.0% were asymptomatic, 3.2% had a recent ocular TIA, 7.6a % had recent hemispheric TIA, 18.0% had a recent stroke, and 9.2% were formerly symptomatic. In patients with recent symptoms, we observed higher rates of stroke/death with increasing neurologic injury severity: asymptomatic 1.1% versus recent ocular TIA 0.8% versus recent hemispheric TIA 2.1% versus recent stroke 3.1% (Ptrend < .01). In formerly symptomatic patients, the rate of stroke/death was higher compared with asymptomatic patients, but this difference was not statistically significant (1.7% vs 1.1%; P = .06). After risk adjustment, compared with asymptomatic patients, there was a higher odds of stroke/death in patients with a recent stroke (odds ratio [OR], 2.8; 95% confidence interval [CI], 2.1-3.7; P < .01), a recent hemispheric TIA (OR, 2.0; 95% CI, 1.3-3.0; P < .01), and former symptoms (OR, 1.6; 95% CI, 1.1-2.5; P = .02), but there was no difference in stroke/death rates in patients with a recent ocular TIA (OR, 0.9; 95% CI, 0.4-2.2; P = .78). CONCLUSIONS: After TCAR, compared with asymptomatic status, a recent stroke and a recent hemispheric TIA were associated with higher stroke/death rates, whereas a recent ocular TIA was associated with similar stroke/death rates. In addition, a formerly symptomatic status was associated with higher stroke/death rates compared with an asymptomatic status. Overall, our findings suggest that classifying patients undergoing TCAR as symptomatic versus asymptomatic may be an oversimplification and that patients specific preoperative neurologic symptoms should instead be used in risk assessment and outcome reporting for TCAR.

Published
2022

25. Intubation Decision Based on Illness Severity and Mortality in COVID-19: An International Study*

Author

Chalkias, Athanasios, Huang, Yiyuan, Ismail, Anis, Pantazopoulos, Ioannis, Papagiannakis, Nikolaos, Bitterman, Brayden, Anderson, Elizabeth, Catalan, Tonimarie, Erne, Grace K., Tilley, Caroline R., Alaka, Abiola, Amadi, Kingsley M., Presswalla, Feriel, Blakely, Pennelope, Bernal-Morell, Enrique, Cebreiros López, Iria, Eugen-Olsen, Jesper, García de Guadiana Romualdo, Luis, Giamarellos-Bourboulis, Evangelos J., Loosen, Sven H., Reiser, Jochen, Tacke, Frank, Skoulakis, Anargyros, Laou, Eleni, Banerjee, Mousumi, Pop-Busui, Rodica, Hayek, Salim S., Hayek, Salim S., Blakely, Pennelope, Launius, Christopher, Berlin, Hanna, Amadi, Kingsley M., Azam, Tariq U., Shadid, Husam, Pan, Michael, O’ Hayer, Patrick, Meloche, Chelsea, Feroze, Rafey, Padalia, Kishan J., Anderson, Elizabeth, Perry, Danny, Bitar, Abbas, Kaakati, Rayan, Zhao, Lili, Zhao, Peiyao, Michaud, Erinleigh, Huang, Yiyuan, Catalan, Tonimarie, Khaleel, Ibrahim, Alaka, Abiola, Pop-Busui, Rodica, Banerjee, Mousumi, Tekumulla, Annika, Tilley, Caroline R., Tripathi, Medha, Vasbinder, Alexi, Bardwell, Alina, Presswalla, Feriel, Nelapudi, Namratha, Erne, Grace K., Chen, Jiazi, Mayette, Nathan, Sulaiman, Noor, Ismail, Anis, Pizzo, Ian, Bitterman, Brayden, Reiser, Jochen, Samelko, Beata, Hlepas, Alexander, Wang, Xuexiang, Patel, Priya, Chalkias, Athanasios, Pantazopoulos, Ioannis, Laou, Eleni, Skoulakis, Anargyros, Papagiannakis, Nikolaos, Eugen-Olsen, Jesper, Altintas, Izzet, Tingleff, Jens, Stauning, Marius, Houlind, Morten Baltzer, Lindstrøm, Mette B, Andersen, Ove, Gamst-Jensen, Hejdi, Hartmann Rasmussen, Line Jee, Rasmussen, Christian, Nehlin, Jan O., Kallemose, Thomas, Parvaiz, Imran, Loosen, Sven H., Luedde, Tom, Keitel, Verena, Giamarellos-Bourboulis, Evangelos J., Adami, Maria-Evangelia, Solomonidi, Nicky, Tsilika, Maria, Saridaki, Maria, Lekakis, Vasileios, Tacke, Frank, Tober-Lau, Pinkus, Mohr, Raphael, Kurth, Florian, Sander, Leif Erik, Jochum, Christoph, Garcia de Guadiana-Romualdo, Luis, Albaladejo-Otón, María Dolores, Rodríguez Mulero, María Dolores, Martínez, María Galindo, Olivo, Marta Hernández, Rodríguez, Valerio Campos, López, Iria Cebreiros, Carrillo, María Arnaldos, Noguera Velasco, Jose Antonio, Pascual Figal, Domingo A., Morell, Enrique Bernal, García, Antonia Alcaraz, Alcaraz García, María José, Martínez, Monica Martínez, Esteban-Torrella, Patricia, and Sancho-Rodríguez, Natalia

Published
2024
Full Text
View/download PDF

28. Guideline for the management of Clostridioides difficile infection in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2024 update

Author

Patel, Priya, Robinson, Paula D., Fisher, Brian T., Phillips, Robert, Morgan, Jessica E., Lehrnbecher, Thomas, Kuczynski, Susan, Koenig, Christa, Haeusler, Gabrielle M., Esbenshade, Adam, Elgarten, Caitlin, Duong, Nathan, Diorio, Caroline, Castagnola, Elio, Beauchemin, Melissa P., Ammann, Roland A., Dupuis, L. Lee, and Sung, Lillian

Published
2024
Full Text
View/download PDF

30. Gaps in Patient Education on Safe Handling and Disposal of Oral Chemotherapy Drugs: A Pilot Prospective Cohort Survey Study.

Author

Yang, Sun, Patel, Priya, Corcoran, Alexandra, Dobberpuhl, Eric, Isidro, Samantha, Le, Dustin, Klassen, Analise, Rho, Jay, Tran, David, Beuttler, Richard, Nassr, Neda, Wong, Siu-Fun, and Lemire, Katherine

Abstract

BACKGROUND: Oral anticancer chemotherapy (OC) has been misperceived as being safer than intravenous chemotherapy, leading to its increased risk of improper handling and disposal. This survey study assessed the knowledge, practices and attitudes of pharmacists and patients regarding OC handling and disposal, gaps in knowledge and barriers to patient education. METHODS: Surveys were developed based on literature review and pilot study validation results. Patients completed a 33-item paper or electronic survey whereas pharmacists completed a 38-item electronic survey. Descriptive statistics and Fishers exact test computed using the R Project were used for analyses. RESULTS: Pharmacist group (16/25, 62.5%) and patient group (14/29, 48.3%) believed that the oral route is safer than IV. Average overall correct response rates for pharmacist and patient groups were 78.3% and 61.9%, respectively. Significant gaps in knowledge between groups were observed in three sections (p < 0.05). Common barriers to providing patient education were insufficient training (70.8%) and insufficient time (50%). CONCLUSION: Pharmacist and patient knowledge, awareness and practices of OC safe handling and disposal are suboptimal. Areas of knowledge gaps and barriers to patient education were identified. Enhanced supports are needed to empower pharmacists to assume an active role in patient education on safe handling and disposal of OC.

Published
2022

36. Highly Pathogenic Avian Influenza A(H5N1) Virus Outbreak in New England Seals, United States

Author

Puryear, Wendy, Sawatzki, Kaitlin, Hill, Nichola, Foss, Alexa, Stone, Jonathon J., Doughty, Lynda, Walk, Dominique, Gilbert, Katie, Murray, Maureen, Cox, Elena, Patel, Priya, Mertz, Zak, Ellis, Stephanie, Taylor, Jennifer, Fauquier, Deborah, Smith, Ainsley, DiGiovanni, Robert A., Jr., van de Guchte, Adriana, Gonzalez- Reiche, Ana Silvia, Khalil, Zain, van Bakel, Harm, Torchetti, Mia K., Lantz, Kristina, Lenoch, Julianna B., and Runstadler, Jonathan

Subjects
New England -- Health aspects, Avian influenza -- Risk factors, Epidemics -- Risk factors -- United States, Harbor seal -- Diseases, Disease transmission -- Risk factors, Health
Abstract

Highly pathogenic avian influenza (HPAI) viruses are of concern because of their pandemic potential, socioeconomic impact during agricultural outbreaks, and risks to wildlife conservation. Since October 2020, HPAI A(H5N1) virus, [...]

Published
2023
Full Text
View/download PDF

50. A Survey of Energy Efficient Schemes in Ad-hoc Networks

Author

Patel, Priya P. and Jhaveri, Rutvij H.

Subjects
Computer Science - Networking and Internet Architecture
Abstract

Ad hoc network is a collection of different types of nodes, which are connected in heterogeneous or homogeneous manner. It is also known as self-organizing-wireless network. The dynamic nature of ad hoc networks make them more attractive, which is used in many different applications. Every coin has two sides: one is the advantage part and other is disadvantages, in the same manner nature of ad hoc network make it more attractive from one side in other hand there are some issues too. Energy efficiency is a core factor which effects on ad hoc network in terms of battery life, throughput, overhead of messages, transmission error. For solving issues of energy constraints, different mechanisms are proposed by various researchers. In this paper, we survey various existing schemes which attempt to improve energy efficiency of different types of ad hoc routing protocol to increase network lifetime. Furthermore we outline future scope of these existing schemes which may help researches to carry out further research in this direction.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results